Treatment of histiocytic lymphoma in Uganda adults.
D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D007275:Injections, Intravenous; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local; D011241:Prednisone / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D014454:Uganda; D014750:Vincristine / Q000627:therapeutic use*
D004338:Drug Combinations; D006834:Hydrazines; D008466:Mechlorethamine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone